Lee, H. S., Chung, M. J., Park, J. Y., Bang, S., Park, S. W., Kim, H. G., . . . Song, S. Y. (2017). A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea. Medicine (Baltimore).
শিকাগো স্টাইলে সাইটেশনLee, Hee Seung, et al. "A Randomized, Multicenter, Phase III Study of Gemcitabine Combined With Capecitabine Versus Gemcitabine Alone As First-line Chemotherapy for Advanced Pancreatic Cancer in South Korea." Medicine (Baltimore) 2017.
এমএলএ সাইটেশনLee, Hee Seung, et al. "A Randomized, Multicenter, Phase III Study of Gemcitabine Combined With Capecitabine Versus Gemcitabine Alone As First-line Chemotherapy for Advanced Pancreatic Cancer in South Korea." Medicine (Baltimore) 2017.